Used in research settings as a synthetic intermediate for developing novel valerenic acid derivatives with potential neuroactive properties. Shows promise in studies related to modulation of GABA receptors, particularly in the investigation of anxiolytic and sedative effects. Due to its structural similarity to valerenic acid, it is explored for enhancing bioavailability and stability in central nervous system-targeted therapeutics. Currently limited to preclinical research with no established clinical use.